BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21222532)

  • 1. Synergy between glutathione peroxidase-1 and astrocytic growth factors suppresses free radical generation and protects dopaminergic neurons against 6-hydroxydopamine.
    Gardaneh M; Gholami M; Maghsoudi N
    Rejuvenation Res; 2011 Apr; 14(2):195-204. PubMed ID: 21222532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of glutathione peroxidase-1 expression and activity by glial cell line-derived neurotrophic factor promotes high-level protection of PC12 cells against 6-hydroxydopamine and hydrogen peroxide toxicities.
    Gharib E; Gardaneh M; Shojaei S
    Rejuvenation Res; 2013 Jun; 16(3):185-99. PubMed ID: 23472740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione peroxidase 1 and glutathione are required to protect mouse astrocytes from iron-mediated hydrogen peroxide toxicity.
    Liddell JR; Hoepken HH; Crack PJ; Robinson SR; Dringen R
    J Neurosci Res; 2006 Aug; 84(3):578-86. PubMed ID: 16721761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin protects dopaminergic cell line PC12 against 6-hydroxydopamine-mediated neurotoxicity via both glutathione-dependent and independent pathways and by inhibiting apoptosis.
    Esmaeilzadeh E; Gardaneh M; Gharib E; Sabouni F
    Neurochem Res; 2013 Aug; 38(8):1590-604. PubMed ID: 23636806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine.
    Barkats M; Millecamps S; Bilang-Bleuel A; Mallet J
    J Neurochem; 2002 Jul; 82(1):101-9. PubMed ID: 12091470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease.
    Ridet JL; Bensadoun JC; Déglon N; Aebischer P; Zurn AD
    Neurobiol Dis; 2006 Jan; 21(1):29-34. PubMed ID: 16023352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase.
    Ishida Y; Nagai A; Kobayashi S; Kim SU
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):66-77. PubMed ID: 16410750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice.
    Miyazaki I; Murakami S; Torigoe N; Kitamura Y; Asanuma M
    J Neurochem; 2016 Jan; 136(1):194-204. PubMed ID: 26485447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
    Power JH; Blumbergs PC
    Acta Neuropathol; 2009 Jan; 117(1):63-73. PubMed ID: 18853169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway.
    Haskew-Layton RE; Payappilly JB; Smirnova NA; Ma TC; Chan KK; Murphy TH; Guo H; Langley B; Sultana R; Butterfield DA; Santagata S; Alldred MJ; Gazaryan IG; Bell GW; Ginsberg SD; Ratan RR
    Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17385-90. PubMed ID: 20855618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, and In Vitro Evaluation of a Novel Probucol Derivative: Protective Activity in Neuronal Cells Through GPx Upregulation.
    Quispe RL; Canto RFS; Jaramillo ML; Barbosa FAR; Braga AL; de Bem AF; Farina M
    Mol Neurobiol; 2018 Oct; 55(10):7619-7634. PubMed ID: 29430618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin.
    Nakamura K; Wright DA; Wiatr T; Kowlessur D; Milstien S; Lei XG; Kang UJ
    J Neurochem; 2000 Jun; 74(6):2305-14. PubMed ID: 10820190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine decreases levels of glutathione peroxidases 1 and 4 in SH-SY5Y neuronal cells: protective effects of selenium.
    Barayuga SM; Pang X; Andres MA; Panee J; Bellinger FP
    Neurotoxicology; 2013 Jul; 37():240-6. PubMed ID: 23721877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probucol Protects Neuronal Cells Against Peroxide-Induced Damage and Directly Activates Glutathione Peroxidase-1.
    Santos DB; Colle D; Moreira ELG; Santos AA; Hort MA; Santos K; Oses JP; Razzera G; Farina M
    Mol Neurobiol; 2020 Aug; 57(8):3245-3257. PubMed ID: 32506382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione peroxidase 1 and a high cellular glutathione concentration are essential for effective organic hydroperoxide detoxification in astrocytes.
    Liddell JR; Dringen R; Crack PJ; Robinson SR
    Glia; 2006 Dec; 54(8):873-9. PubMed ID: 16998864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione peroxidase-1 expression enhances recovery of human breast carcinoma cells from hyperoxic cell cycle arrest.
    Bilodeau JF; Patenaude A; Piedboeuf B; Carrier C; Petrov P; Faure R; Mirault ME
    Free Radic Biol Med; 2002 Nov; 33(9):1279-89. PubMed ID: 12398936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system.
    Hou JG; Cohen G; Mytilineou C
    J Neurochem; 1997 Jul; 69(1):76-83. PubMed ID: 9202296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection.
    Kikuoka R; Miyazaki I; Kubota N; Maeda M; Kagawa D; Moriyama M; Sato A; Murakami S; Kitamura Y; Sendo T; Asanuma M
    Sci Rep; 2020 Nov; 10(1):20698. PubMed ID: 33244123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished Akt phosphorylation in neurons lacking glutathione peroxidase-1 (Gpx1) leads to increased susceptibility to oxidative stress-induced cell death.
    Taylor JM; Ali U; Iannello RC; Hertzog P; Crack PJ
    J Neurochem; 2005 Jan; 92(2):283-93. PubMed ID: 15663476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.
    Offen D; Sherki Y; Melamed E; Fridkin M; Brenneman DE; Gozes I
    Brain Res; 2000 Jan; 854(1-2):257-62. PubMed ID: 10784133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.